Kontigo Care AB (publ) (KONT.ST)
SEK 2.64
(-1.49%)
SEK 2.64
(-1.49%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 212 Thousand SEK | -92.68% |
| 2022 | 2.89 Million SEK | 341.4% |
| 2021 | -1.19 Million SEK | 6.56% |
| 2020 | -1.28 Million SEK | 18.69% |
| 2019 | -1.57 Million SEK | 76.52% |
| 2018 | -6.72 Million SEK | 53.21% |
| 2017 | -14.36 Million SEK | 26.82% |
| 2016 | -19.63 Million SEK | -37.41% |
| 2015 | -14.28 Million SEK | -1084.43% |
| 2014 | -1.2 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 108 Thousand SEK | 130.68% |
| 2024 Q2 | 473 Thousand SEK | 337.96% |
| 2023 Q3 | 1.51 Million SEK | 404.41% |
| 2023 Q4 | -352 Thousand SEK | -123.17% |
| 2023 FY | 212 Thousand SEK | -92.68% |
| 2023 Q1 | -476 Thousand SEK | -393.83% |
| 2023 Q2 | -499 Thousand SEK | -4.83% |
| 2022 Q3 | 1.37 Million SEK | 15.16% |
| 2022 FY | 2.89 Million SEK | 341.4% |
| 2022 Q2 | 1.19 Million SEK | 628.05% |
| 2022 Q1 | 164 Thousand SEK | 136.31% |
| 2022 Q4 | 162 Thousand SEK | -88.22% |
| 2021 Q3 | 345 Thousand SEK | 153.41% |
| 2021 FY | -1.19 Million SEK | 6.56% |
| 2021 Q1 | -400 Thousand SEK | -539.2% |
| 2021 Q2 | -646 Thousand SEK | -61.5% |
| 2021 Q4 | -451.63 Thousand SEK | -230.91% |
| 2020 Q4 | -62.57 Thousand SEK | -135.56% |
| 2020 Q3 | 176 Thousand SEK | 129.78% |
| 2020 FY | -1.28 Million SEK | 18.69% |
| 2020 Q2 | -591 Thousand SEK | 17.46% |
| 2020 Q1 | -716 Thousand SEK | -792.04% |
| 2019 FY | -1.57 Million SEK | 76.52% |
| 2019 Q3 | -2000.00 SEK | 99.7% |
| 2019 Q4 | 103.46 Thousand SEK | 5273.1% |
| 2019 Q2 | -672 Thousand SEK | 17.65% |
| 2019 Q1 | -816 Thousand SEK | 46.52% |
| 2018 Q4 | -1.52 Million SEK | -63.19% |
| 2018 Q3 | -935 Thousand SEK | 54.08% |
| 2018 Q1 | -2.22 Million SEK | 35.32% |
| 2018 Q2 | -2.03 Million SEK | 8.49% |
| 2018 FY | -6.72 Million SEK | 53.21% |
| 2017 Q2 | -4.61 Million SEK | -12.56% |
| 2017 FY | -14.36 Million SEK | 26.82% |
| 2017 Q4 | -3.43 Million SEK | -55.44% |
| 2017 Q1 | -4.09 Million SEK | 11.22% |
| 2017 Q3 | -2.21 Million SEK | 52.04% |
| 2016 Q1 | -4.97 Million SEK | -127.31% |
| 2016 Q4 | -4.61 Million SEK | -15.54% |
| 2016 Q2 | -6.04 Million SEK | -21.58% |
| 2016 FY | -19.63 Million SEK | -37.41% |
| 2016 Q3 | -3.99 Million SEK | 33.9% |
| 2015 FY | -14.28 Million SEK | -1084.43% |
| 2015 Q4 | -2.18 Million SEK | 30.41% |
| 2015 Q1 | -3.8 Million SEK | -1242.67% |
| 2015 Q2 | -5.15 Million SEK | -35.6% |
| 2015 Q3 | -3.14 Million SEK | 39.02% |
| 2014 Q4 | -283.09 Thousand SEK | 43.27% |
| 2014 Q1 | -211.5 Thousand SEK | 0.0% |
| 2014 FY | -1.2 Million SEK | 0.0% |
| 2014 Q3 | -499 Thousand SEK | -26.97% |
| 2014 Q2 | -393 Thousand SEK | -85.82% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aino Health AB (publ) | -10.66 Million SEK | 101.989% |
| Bonzun AB (publ) | 13.88 Million SEK | 98.473% |
| Medhelp Care Aktiebolag (publ) | -11.01 Million SEK | 101.926% |
| RaySearch Laboratories AB (publ) | 81.57 Million SEK | 99.74% |
| Surgical Science Sweden AB (publ) | 233.97 Million SEK | 99.909% |